Q2 offers the expertise and experience to deliver innovative therapeutics to the market. Our preclinical, clinical, biostatistics and regulatory consultants bring a broad range of knowledge and in-depth understanding of global and local market landscape and regulatory guidelines. Q2 team creates tailored development strategies to meet the individual needs, from early phase to late-stage development.
Q2 has deep experience in development of pharmaceutical products in rare diseases and pediatric indications.
Q2 offers statistical consulting to provide best strategies for study designs, sample size and power assessment, protocol development, regulatory interactions, CSR, ISS/ISE and NDA submissions.
Copyright ©2018-now Q2 Business Intelligence